Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Diseases of the Thyroid

  Free Subscription

Articles published in Endocr J

Retrieve available abstracts of 94 articles:
HTML format

Single Articles

    November 2021
  1. SUNADA N, Hanayama Y, Yamamoto K, Nakano Y, et al
    Clinical utility of urinary levels of catecholamines and their fraction ratios related to heart rate and thyroid function.
    Endocr J. 2021 Nov 3. doi: 10.1507/endocrj.EJ21-0488.
    PubMed     Abstract available

  2. KURE S, Chiba T, Ebina A, Toda K, et al
    Correlation between low expression of protein disulfide isomerase A3 and lymph node metastasis in papillary thyroid carcinoma and poor prognosis: a clinicopathological study of 1,139 cases with long-term follow-up.
    Endocr J. 2021 Nov 2. doi: 10.1507/endocrj.EJ21-0394.
    PubMed     Abstract available

    October 2021
  3. SUZUKI A, Hirokawa M, Kanematsu R, Tanaka A, et al
    B-cell to T-cell ratio as a novel indicator in flow cytometry in the diagnosis of thyroid lymphoma.
    Endocr J. 2021 Oct 21. doi: 10.1507/endocrj.EJ21-0451.
    PubMed     Abstract available

  4. YAMAGUCHI Y, Uchimura K, Takahashi K, Ishii T, et al
    Hyperthyroidism exacerbates ischemic reperfusion injury in the kidney.
    Endocr J. 2021 Oct 9. doi: 10.1507/endocrj.EJ21-0395.
    PubMed     Abstract available

  5. FUKATA S, Ito M, Nishikawa M, Kasahara T, et al
    Hypothyroidism due to nephrotic syndrome: a notable clinical entity.
    Endocr J. 2021 Oct 6. doi: 10.1507/endocrj.EJ21-0387.
    PubMed     Abstract available

    September 2021
  6. CAO X, Zhu J, Li X, Ma Y, et al
    Expression of CXCR4 and CXCR7 in papillary thyroid carcinoma and adjacent tissues and their relationship with pathologic indicators of tumor aggressiveness.
    Endocr J. 2021 Sep 28. doi: 10.1507/endocrj.EJ21-0076.
    PubMed     Abstract available

  7. ZHENG H, Fu Q, Ma K, Shi S, et al
    Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET/AKT signaling.
    Endocr J. 2021 Sep 25. doi: 10.1507/endocrj.EJ20-0498.
    PubMed     Abstract available

  8. OHBA K, Sasaki S, Misawa Nakamura H, Matsushita A, et al
    Clinical outcomes of 34 patients with resistance to thyroid hormone beta: a twenty-year experience in Japan.
    Endocr J. 2021 Sep 22. doi: 10.1507/endocrj.EJ21-0390.
    PubMed     Abstract available

  9. OKAMURA K, Ibayashi H, Sato K, Fujikawa M, et al
    A case of Graves' disease presenting with internal ophthalmoplegia during methylmercaptoimidazole treatment.
    Endocr J. 2021 Sep 18. doi: 10.1507/endocrj.EJ21-0340.
    PubMed     Abstract available

  10. KAMMA H, Kameyama K, Kondo T, Imamura Y, et al
    Pathological diagnosis of general rules for the description of thyroid cancer by Japanese Society of Thyroid Pathology and Japan Association of Endocrine Surgery.
    Endocr J. 2021 Sep 15. doi: 10.1507/endocrj.EJ21-0388.
    PubMed     Abstract available

  11. MINAKATA M, Ito M, Kishi T, Hada M, et al
    The magnitude of increased Levothyroxine dose during pregnancy in patients on thyroid-stimulating hormone (TSH) suppression treatment after total thyroidectomy for papillary carcinoma.
    Endocr J. 2021 Sep 14. doi: 10.1507/endocrj.EJ21-0109.
    PubMed     Abstract available

  12. LIU H, Yao XY, Zheng ZQ, Chen SJ, et al
    Analysis of risk factors for posterior laryngeal recurrent nerve metastasis in micropapillary thyroid carcinoma.
    Endocr J. 2021 Sep 7. doi: 10.1507/endocrj.EJ21-0073.
    PubMed     Abstract available

    August 2021
  13. YOKOMICHI H, Mochizuki M, Kojima R, Horiuchi S, et al
    Mother's iodine exposure and infants' hypothyroidism: the Japan environment and children's study.
    Endocr J. 2021 Aug 26. doi: 10.1507/endocrj.EJ21-0168.
    PubMed     Abstract available

  14. TOI N, Kurajoh M, Miyaoka D, Nagata Y, et al
    Bexarotene-induced central hypothyroidism assessed by TRH stimulation test in cutaneous T-cell lymphoma patients.
    Endocr J. 2021 Aug 25. doi: 10.1507/endocrj.EJ21-0313.
    PubMed     Abstract available

  15. KIM J, Shin JH, Oh YL, Hahn SY, et al
    Approach to Bethesda system category III thyroid nodules according to US-risk stratification.
    Endocr J. 2021 Aug 18. doi: 10.1507/endocrj.EJ21-0300.
    PubMed     Abstract available

    July 2021
  16. WATANABE N, Yoshimura Noh J, Akamizu T, Yamada M, et al
    Survey of the actual administration of thiamazole for hyperthyroidism in Japan by the Japan Thyroid Association.
    Endocr J. 2021 Jul 29. doi: 10.1507/endocrj.EJ21-0238.
    PubMed     Abstract available

  17. KIHARA M, Miyauchi A, Hirokawa M, Masuoka H, et al
    Long-term outcomes of cytologically benign thyroid tumors: a retrospective analysis of 3,102 patients at a single institution.
    Endocr J. 2021 Jul 16. doi: 10.1507/endocrj.EJ21-0252.
    PubMed     Abstract available

  18. WATANABE D, Yagasaki H, Narusawa H, Saito T, et al
    Screening of frequent variants associated with congenital hypothyroidism: a comparison with next generation sequencing.
    Endocr J. 2021 Jul 8. doi: 10.1507/endocrj.EJ21-0353.
    PubMed     Abstract available

  19. ITO Y, Hirokawa M, Kousaka K, Ito M, et al
    Diagnosis and management of hyalinizing trabecular tumor of the thyroid: a single-institution experience.
    Endocr J. 2021 Jul 6. doi: 10.1507/endocrj.EJ21-0143.
    PubMed     Abstract available

  20. OBA T, Maeno K, Amitani M, Shimizu T, et al
    Prognostic significance of neutrophil-to-lymphocyte ratio for long-term outcomes in patients with poorly differentiated thyroid cancer.
    Endocr J. 2021 Jul 2. doi: 10.1507/endocrj.EJ21-0237.
    PubMed     Abstract available

    June 2021
  21. FUJISHIMA M, Miyauchi A, Ito Y, Kudo T, et al
    Evaluation of the diagnostic utility of the aminotransferase/lactate dehydrogenase ratio for the suspension of tissue specimens during thyroid surgery for the identification of parathyroid tissue.
    Endocr J. 2021 Jun 15. doi: 10.1507/endocrj.EJ21-0128.
    PubMed     Abstract available

  22. HAYASHI T, Akiyama N, Kanematsu R, Higuchi M, et al
    Potential role of mobile rapid on-site evaluation((R)) in thyroid fine-needle aspiration cytology to reduce delayed repeated aspiration.
    Endocr J. 2021 Jun 12. doi: 10.1507/endocrj.EJ21-0010.
    PubMed     Abstract available

  23. MAO Y, Huo Y, Li J, Zhao Y, et al
    circRPS28 (hsa_circ_0049055) is a novel contributor for papillary thyroid carcinoma by regulating cell growth and motility via functioning as ceRNA for miR-345-5p to regulate frizzled family receptor 8 (FZD8).
    Endocr J. 2021 Jun 10. doi: 10.1507/endocrj.EJ21-0072.
    PubMed     Abstract available

  24. HANAI S, Uchimura K, Takahashi K, Ishii T, et al
    Hypoxia-induced thyroid hormone receptor expression regulates cell-cycle progression in renal tubule epithelial cells.
    Endocr J. 2021 Jun 8. doi: 10.1507/endocrj.EJ21-0245.
    PubMed     Abstract available

  25. LI X, Yang S, Zhao C, Yang J, et al
    CircHACE1 functions as a competitive endogenous RNA to curb differentiated thyroid cancer progression by upregulating Tfcp2L1 through adsorbing miR-346.
    Endocr J. 2021 Jun 4. doi: 10.1507/endocrj.EJ20-0806.
    PubMed     Abstract available

    May 2021
  26. OKADA J, Isoda A, Hoshi H, Watanabe T, et al
    Free triiodothyronine /free thyroxine ratio as an index of deiodinase type 1 and 2 activities negatively correlates with casual serum insulin levels in patients with type 2 diabetes mellitus.
    Endocr J. 2021 May 11. doi: 10.1507/endocrj.EJ21-0169.
    PubMed     Abstract available

  27. KAKUDO K, Liu Z, Bai Y, Li Y, et al
    How to identify indolent thyroid tumors unlikely to recur and cause cancer death immediately after surgery-Risk stratification of papillary thyroid carcinoma in young patients.
    Endocr J. 2021 May 11. doi: 10.1507/endocrj.EJ21-0018.
    PubMed     Abstract available

  28. MIZOKAMI T, Hamada K, Maruta T, Higashi K, et al
    Utility of outpatient fractionated radioiodine therapy for Graves disease involving a large goiter measuring more than 100 mL in volume.
    Endocr J. 2021 May 11. doi: 10.1507/endocrj.EJ20-0836.
    PubMed     Abstract available

  29. IIJIMA T, Jojima T, Hosonuma S, Ohhira E, et al
    Symptomatic hypocalcemia after treatment for hyperthyroidism in a woman with chromosome 22q11.2 deletion syndrome complicated by Graves' disease: longitudinal changes in the number of subsets of CD4 and CD8 lymphocytes after thyroidectomy.
    Endocr J. 2021 May 11. doi: 10.1507/endocrj.EJ20-0717.
    PubMed     Abstract available

    April 2021
  30. DING X, Zhao Y, Zhu CY, Wu LP, et al
    The association between subclinical hypothyroidism and metabolic syndrome: an update meta-analysis of observational studies.
    Endocr J. 2021 Apr 21. doi: 10.1507/endocrj.EJ20-0796.
    PubMed     Abstract available

  31. SAKAMOTO A, Hirokawa M, Ito M, Naganuma H, et al
    Introduction of histological classification and cytology reporting format of the Japanese General Rules for the Description of Thyroid Cancer with a special focus on the differences of the WHO Histological Classification and The Bethesda System of Thy
    Endocr J. 2021 Apr 13. doi: 10.1507/endocrj.EJ21-0077.
    PubMed     Abstract available

  32. TAGAMI T
    An overview of thyroid function tests in subjects with resistance to thyroid hormone and related disorders.
    Endocr J. 2021 Apr 6. doi: 10.1507/endocrj.EJ21-0059.
    PubMed     Abstract available

    March 2021
  33. HORIGUCHI K, Yoshida Y, Iwaku K, Emoto N, et al
    Position paper from the Japan Thyroid Association task force on the management of low-risk papillary thyroid microcarcinoma (T1aN0M0) in adults.
    Endocr J. 2021 Mar 23. doi: 10.1507/endocrj.EJ20-0692.
    PubMed     Abstract available

  34. ITO Y, Hirokawa M, Fujishima M, Masuoka H, et al
    Prognostic significance of vascular invasion and cell-proliferation activity in widely invasive follicular carcinoma of the thyroid.
    Endocr J. 2021 Mar 20. doi: 10.1507/endocrj.EJ21-0064.
    PubMed     Abstract available

  35. LIU Y, Chen G, Wang B, Wu H, et al
    Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
    Endocr J. 2021 Mar 13. doi: 10.1507/endocrj.EJ20-0726.
    PubMed     Abstract available

  36. SHIMATSU A, Nakamura A, Takahashi Y, Fujio S, et al
    Preoperative and long-term efficacy and safety of lanreotide autogel in patients with thyrotropin-secreting pituitary adenoma: a multicenter, single-arm, phase 3 study in Japan.
    Endocr J. 2021 Mar 11. doi: 10.1507/endocrj.EJ20-0707.
    PubMed     Abstract available

    February 2021
  37. HIRUMA M, Sasano Y, Watanabe N, Yoshihara A, et al
    Propylthiouracil-induced otitis media with anti-neutrophil cytoplasmic antibody-associated vasculitis: a case report and review of the literature.
    Endocr J. 2021;68:145-151.
    PubMed     Abstract available

  38. WANG D, Zheng Y
    Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
    Endocr J. 2021 Feb 20. doi: 10.1507/endocrj.EJ20-0353.
    PubMed     Abstract available

  39. TANIMURA Y, Kiriya M, Kawashima A, Mori H, et al
    Regulation of solute carrier family 26 member 7 (Slc26a7) by thyroid stimulating hormone in thyrocytes.
    Endocr J. 2021 Feb 14. doi: 10.1507/endocrj.EJ20-0502.
    PubMed     Abstract available

  40. NISHIHARA E, Ito Y, Kudo T, Ito M, et al
    Favorable outcomes of papillary thyroid microcarcinoma concurrent with Graves' disease after radioactive iodine therapy.
    Endocr J. 2021 Feb 6. doi: 10.1507/endocrj.EJ20-0753.
    PubMed     Abstract available

    January 2021
  41. FUKUDA N, Toda K, Wang X, Ohmoto A, et al
    Prognostic significance of 8 weeks' relative dose intensity of lenvatinib in treatment of radioiodine-refractory differentiated thyroid cancer patients.
    Endocr J. 2021 Jan 28. doi: 10.1507/endocrj.EJ20-0754.
    PubMed     Abstract available

  42. YAMADA Y, Orita M, Matsunaga H, Yamaguchi T, et al
    Risk perception regarding implementation of iodine thyroid blocking during a nuclear disaster of mothers living near a nuclear power station in Japan.
    Endocr J. 2021 Jan 21. doi: 10.1507/endocrj.EJ20-0627.
    PubMed     Abstract available

  43. DAMIAO CP, Montero JRG, Moran MBH, de Oliveira Marcal E Silva Carvalho ME, et al
    Application of thermography in the diagnostic investigation of thyroid nodules.
    Endocr J. 2021 Jan 21. doi: 10.1507/endocrj.EJ20-0541.
    PubMed     Abstract available

  44. MA J, Kan Z
    Circular RNA circ_0008274 enhances the malignant progression of papillary thyroid carcinoma via modulating solute carrier family 7 member 11 by sponging miR-154-3p.
    Endocr J. 2021 Jan 19. doi: 10.1507/endocrj.EJ20-0453.
    PubMed     Abstract available

  45. SPEER G, Somogyi P
    Thyroid complications of SARS and coronavirus disease 2019 (COVID-19).
    Endocr J. 2021 Jan 19. doi: 10.1507/endocrj.EJ20-0443.
    PubMed     Abstract available

  46. WATANABE T, Temma Y, Okada J, Yamada E, et al
    In patients with type 2 diabetes the presence of Hashimoto's thyroiditis reduces the beneficial effect of dipeptidyl peptidase-4 inhibitor on plasma glucose control.
    Endocr J. 2021 Jan 7. doi: 10.1507/endocrj.EJ20-0620.
    PubMed     Abstract available

    December 2020
  47. TAKESHIMA K, Li Y, Kakudo K, Hirokawa M, et al
    Proposal of diagnostic criteria for IgG4-related thyroid disease.
    Endocr J. 2020 Dec 12. doi: 10.1507/endocrj.EJ20-0557.
    PubMed     Abstract available

    November 2020
  48. TAKAHASHI S, Ito M, Masaki Y, Hada M, et al
    Association between serum thyroid hormone balance and thyroid volume in patients treated with levothyroxine monotherapy for hypothyroidism.
    Endocr J. 2020 Nov 25. doi: 10.1507/endocrj.EJ20-0542.
    PubMed     Abstract available

  49. MIZUNO S, Inaba H, Kobayashi KI, Kubo K, et al
    A case of postpartum thyroiditis following SARS-CoV-2 infection.
    Endocr J. 2020 Nov 12. doi: 10.1507/endocrj.EJ20-0553.
    PubMed     Abstract available

    October 2020
  50. YUAN X, Wang J, Gao Y, Wang H, et al
    Impact of maternal thyroid hormone in late pregnancy on adverse birth outcomes: A retrospective cohort study in China.
    Endocr J. 2020 Oct 27. doi: 10.1507/endocrj.EJ20-0377.
    PubMed     Abstract available

  51. LI S, Li W, Sheng B, Zhu X, et al
    Relationship between thyroid disorders and uterine fibroids among reproductive-age women.
    Endocr J. 2020 Oct 8. doi: 10.1507/endocrj.EJ20-0340.
    PubMed     Abstract available

  52. INABA H, Ariyasu H, Iwakura H, Kurimoto C, et al
    Distinct clinical features and prognosis between persistent and temporary thyroid dysfunctions by immune-checkpoint inhibitors.
    Endocr J. 2020 Oct 3. doi: 10.1507/endocrj.EJ20-0371.
    PubMed     Abstract available

  53. TSUNEMI A, Uchida T, Kuroda K, Ikemoto Y, et al
    Effect of thyroxine treatment on pregnancy outcomes in infertile Japanese women with TSH levels between 2.5 muIU/mL and the upper reference limit: a retrospective study.
    Endocr J. 2020 Oct 1. doi: 10.1507/endocrj.EJ20-0380.
    PubMed     Abstract available

    September 2020
  54. TAKAGI S, Hirokawa M, Nagashima K, Higuchi M, et al
    Diagnostic significance of apical membranous and cytoplasmic dot-like CD26 expression in encapsulated follicular variant of papillary thyroid carcinoma: a useful marker for capsular invasion.
    Endocr J. 2020 Sep 2. doi: 10.1507/endocrj.EJ19-0501.
    PubMed     Abstract available

    August 2020
  55. ISHIHARA S, Onoda N, Noda S, Tauchi Y, et al
    Treatment of anaplastic thyroid cancer with tyrosine kinase inhibitors targeted on the tumor vasculature: initial experience in clinical practice.
    Endocr J. 2020 Aug 29. doi: 10.1507/endocrj.EJ20-0287.
    PubMed     Abstract available

  56. SAKAMOTO A, Matsuzuka T, Yamaya Y, Suzuki S, et al
    Cytological examination of the thyroid in children and adolescents after the Fukushima Nuclear Power Plant accident: the Fukushima Health Management Survey.
    Endocr J. 2020 Aug 20. doi: 10.1507/endocrj.EJ20-0235.
    PubMed     Abstract available

  57. SUGIYAMA K, Kobayashi S, Kurihara I, Miyashita K, et al
    Effect of long-term amiodarone treatment on thyroid function in euthyroid Japanese patients: a 12-month retrospective analysis.
    Endocr J. 2020 Aug 18. doi: 10.1507/endocrj.EJ20-0307.
    PubMed     Abstract available

  58. OBA T, Chino T, Soma A, Shimizu T, et al
    Comparative efficacy and safety of tyrosine kinase inhibitors for thyroid cancer: a systematic review and meta-analysis.
    Endocr J. 2020 Aug 18. doi: 10.1507/endocrj.EJ20-0171.
    PubMed     Abstract available

    July 2020
  59. YI W, Kim BH, Kim M, Ryang SR, et al
    Short-term bone marrow suppression in differentiated thyroid cancer patients after radioactive iodine treatment.
    Endocr J. 2020 Jul 28. doi: 10.1507/endocrj.EJ20-0242.
    PubMed     Abstract available

  60. OSHITA M, Ito Y, Miyamoto T, Ota H, et al
    Ultrasound findings of noninvasive follicular thyroid neoplasm with papillary-like nuclear features compared with those of follicular variant of papillary carcinoma and encapsulated papillary carcinoma: a single-institution study in Japan.
    Endocr J. 2020 Jul 16. doi: 10.1507/endocrj.EJ20-0254.
    PubMed     Abstract available

  61. PACE C, Tumino D, Russo M, Le Moli R, et al
    Role of selenium and myo-inositol supplementation on autoimmune thyroiditis progression.
    Endocr J. 2020 Jul 15. doi: 10.1507/endocrj.EJ20-0062.
    PubMed     Abstract available

  62. HIROKAWA M, Suzuki A, Hashimoto Y, Satoh S, et al
    Prevalence and diagnostic challenges of thyroid lymphoma: a multi-institutional study in non-Western countries.
    Endocr J. 2020 Jul 9. doi: 10.1507/endocrj.EJ20-0202.
    PubMed     Abstract available

    June 2020
  63. HIROKAWA M, Higuchi M, Suzuki A, Hayashi T, et al
    Prevalence and diagnostic significance of noninvasive follicular thyroid neoplasm with papillary-like nuclear features among tumors previously diagnosed as follicular adenoma: a single-institutional study in Japan.
    Endocr J. 2020 Jun 26. doi: 10.1507/endocrj.EJ20-0198.
    PubMed     Abstract available

  64. ITO Y, Hirokawa M, Hayashi T, Ota H, et al
    Case report: exceptionally rapid growth character of hobnail variant of papillary thyroid carcinoma: a report of four cases.
    Endocr J. 2020 Jun 18. doi: 10.1507/endocrj.EJ20-0248.
    PubMed     Abstract available

  65. TAKESHIMA K, Ariyasu H, Uraki S, Morita S, et al
    False-positive staining of thyroglobulin distinguished from mixed medullary and follicular thyroid carcinoma by duplex in situ hybridization.
    Endocr J. 2020 Jun 10. doi: 10.1507/endocrj.EJ20-0169.
    PubMed     Abstract available

  66. SUZUKI N, Yoshihara A, Yoshimura Noh J, Kinoshita K, et al
    TRAb elevations occurred even in the third trimester; a case of a mother of a child with neonatal thyroid dysfunction, who received radioactive iodine therapy for Graves' disease.
    Endocr J. 2020 Jun 10. doi: 10.1507/endocrj.EJ20-0039.
    PubMed     Abstract available

    May 2020
    Impact of gross extrathyroidal extension into major neck structures on the prognosis of papillary thyroid carcinoma according to the American Joint Committee on Cancer eighth edition.
    Endocr J. 2020 May 28. doi: 10.1507/endocrj.EJ19-0523.
    PubMed     Abstract available

  68. OTSUKI N, Shimoda H, Morita N, Furukawa T, et al
    Salvage surgery for structural local recurrence of papillary thyroid cancer: recurrence patterns and surgical outcome.
    Endocr J. 2020 May 27. doi: 10.1507/endocrj.EJ20-0152.
    PubMed     Abstract available

  69. DAI H, Zhang L, Han X, Zhao H, et al
    Body mass index (BMI) is associated with serum thyroid-stimulating hormone (TSH) level in infertile women: a cross-sectional study.
    Endocr J. 2020 May 15. doi: 10.1507/endocrj.EJ19-0441.
    PubMed     Abstract available

    April 2020
  70. MATSUZU K, Sugino K, Masudo K, Mori K, et al
    Clinical outcomes and risk stratification for papillary thyroid carcinoma presenting with distant metastasis before the era of tyrosine kinase inhibitors.
    Endocr J. 2020 Apr 28. doi: 10.1507/endocrj.EJ20-0081.
    PubMed     Abstract available

  71. KO J, Kim JY, Kim JW, Yoon JS, et al
    Anti-oxidative and anti-adipogenic effects of caffeine in an in vitro model of Graves' orbitopathy.
    Endocr J. 2020;67:439-447.
    PubMed     Abstract available

  72. INAGAKI Y, Takeshima K, Nishi M, Ariyasu H, et al
    The influence of thyroid autoimmunity on pregnancy outcome in infertile women: a prospective study.
    Endocr J. 2020 Apr 25. doi: 10.1507/endocrj.EJ19-0604.
    PubMed     Abstract available

  73. CHUNG JH
    BRAF and TERT promoter mutations: clinical application in thyroid cancer.
    Endocr J. 2020 Apr 21. doi: 10.1507/endocrj.EJ20-0063.
    PubMed     Abstract available

  74. ITO Y, Onoda N, Okamoto T
    The revised clinical practice guidelines on the management of thyroid tumors by the Japan Associations of Endocrine Surgeons: Core questions and recommendations for treatments of thyroid cancer.
    Endocr J. 2020 Apr 9. doi: 10.1507/endocrj.EJ20-0025.
    PubMed     Abstract available

  75. OKAMURA K, Bandai S, Fujikawa M, Sato K, et al
    Clinical experience of treating Graves' hyperthyroidism complicated with malignancy-The possible role of potassium iodide for avoiding the risk of thionamide-associated neutropenia.
    Endocr J. 2020 Apr 2. doi: 10.1507/endocrj.EJ20-0016.
    PubMed     Abstract available

    March 2020
  76. CHEN Y, Tai HY
    Levothyroxine in the treatment of overt or subclinical hypothyroidism: a systematic review and meta-analysis.
    Endocr J. 2020 Mar 31. doi: 10.1507/endocrj.EJ19-0583.
    PubMed     Abstract available

  77. PAPANIKOLAOU A, Katsamakas M, Boudina M, Pamporaki C, et al
    Intrathyroidal parathyroid adenoma mimicking thyroid cancer.
    Endocr J. 2020 Mar 26. doi: 10.1507/endocrj.EJ19-0594.
    PubMed     Abstract available

  78. SUZUKI N, Yoshimura Noh J, Sugisawa C, Hoshiyama A, et al
    Therapeutic efficacy and limitations of potassium iodide for patients newly diagnosed with Graves' disease.
    Endocr J. 2020 Mar 18. doi: 10.1507/endocrj.EJ19-0379.
    PubMed     Abstract available

  79. ZHOU J, Dong X, Liu Y, Jia Y, et al
    Gestational hypothyroidism elicits more pronounced lipid dysregulation in mice than pre-pregnant hypothyroidism.
    Endocr J. 2020 Mar 10. doi: 10.1507/endocrj.EJ19-0455.
    PubMed     Abstract available

    February 2020
  80. ZHU XH, Zhou JN, Qian YY, Yang K, et al
    Diagnostic values of thyroglobulin in lymph node fine-needle aspiration washout: a systematic review and meta-analysis diagnostic values of FNA-Tg.
    Endocr J. 2020;67:113-123.
    PubMed     Abstract available

  81. SHIMAZAKI S, Kazukawa I, Mori K, Kihara M, et al
    Factors predicting endocrine late effects in childhood cancer survivors from a Japanese hospital.
    Endocr J. 2020;67:131-140.
    PubMed     Abstract available

  82. OKAMOTO M, Watanabe M, Inoue N, Ogawa K, et al
    Gene polymorphisms of VEGF and VEGFR2 are associated with the severity of Hashimoto's disease and the intractability of Graves' disease, respectively.
    Endocr J. 2020 Feb 20. doi: 10.1507/endocrj.EJ19-0480.
    PubMed     Abstract available

  83. NISHIHARA E, Kudo T, Ito M, Fukata S, et al
    Papillary thyroid carcinomas are highly obscured by inflammatory hypoechoic regions caused by subacute thyroiditis: a longitudinal evaluation of 710 patients using ultrasonography.
    Endocr J. 2020 Feb 15. doi: 10.1507/endocrj.EJ19-0597.
    PubMed     Abstract available

    January 2020
  84. UCHIDA T, Yamaguchi H, Kushima C, Yonekawa T, et al
    Elevated levels of circulating fibroblast growth factor 23 with hypercalcemia following discontinuation of denosumab.
    Endocr J. 2020;67:31-35.
    PubMed     Abstract available

  85. OHASHI R
    Solid variant of papillary thyroid carcinoma: an under-recognized entity.
    Endocr J. 2020 Jan 25. doi: 10.1507/endocrj.EJ19-0414.
    PubMed     Abstract available

  86. OHBA K, Okada E, Goto Y, Suzuki S, et al
    Influence of thyroid dysfunction on brain natriuretic peptide level in health examination participants.
    Endocr J. 2020 Jan 18. doi: 10.1507/endocrj.EJ19-0380.
    PubMed     Abstract available

    December 2019
  87. HIROMATSU Y, Eguchi H, Matsuo Y, Kato T, et al
    Role of a new bioassay for thyroid-stimulating antibodies (aequorin TSAb) in Graves' ophthalmopathy.
    Endocr J. 2019 Dec 10. doi: 10.1507/endocrj.EJ19-0398.
    PubMed     Abstract available

  88. CHEN Z, Wang Y, Ding X, Zhang M, et al
    The proportion of peripheral blood Tregs among the CD4+ T cells of autoimmune thyroid disease patients: a meta-analysis.
    Endocr J. 2019 Dec 10. doi: 10.1507/endocrj.EJ19-0307.
    PubMed     Abstract available

  89. SANTRAC N, Markovic I, Medic Milijic N, Goran M, et al
    Sentinel lymph node biopsy in medullary thyroid microcarcinomas.
    Endocr J. 2019 Dec 3. doi: 10.1507/endocrj.EJ19-0409.
    PubMed     Abstract available

    November 2019
  90. ITO Y, Miyauchi A, Yamamoto M, Masuoka H, et al
    Subset analysis of the Japanese risk classification guidelines for papillary thyroid carcinoma.
    Endocr J. 2019 Nov 27. doi: 10.1507/endocrj.EJ19-0387.
    PubMed     Abstract available

  91. FUJIMOTO N, Matsuu-Matsuyama M, Nakashima M
    Morphological and functional changes in neonatally X-irradiated thyroid gland in rats.
    Endocr J. 2019 Nov 19. doi: 10.1507/endocrj.EJ19-0245.
    PubMed     Abstract available

    October 2019
  92. HOZUMI K, Fukuoka H, Odake Y, Takeuchi T, et al
    Acromegaly caused by a somatotroph adenoma in patient with neurofibromatosis type 1.
    Endocr J. 2019;66:853-857.
    PubMed     Abstract available

  93. OHBA K, Maekawa M, Iwahara K, Suzuki Y, et al
    Abnormal thyroid hormone response to TRH in a case of macro-TSH and the cut-off value for screening cases of inappropriate TSH elevation.
    Endocr J. 2019 Oct 24. doi: 10.1507/endocrj.EJ19-0320.
    PubMed     Abstract available

    July 2019
  94. ARIMA H, Iwama S, Inaba H, Ariyasu H, et al
    Management of immune-related adverse events in endocrine organs induced by immune checkpoint inhibitors: clinical guidelines of the Japan Endocrine Society.
    Endocr J. 2019;66:581-586.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.